The Immunovant eCOA App is intended for use to collect weekly study dosing
The Immunovant eCOA App is intended for use to collect weekly study dosing information in a dosing diary relating to the IMVT-1401-2401 clinical trial. Patients must be given accounts by a participating site in order to log in to the app.
Janssen eCOA App is intended for use to collect participant reported outcomes...
CSL Seqirus eCOA App is intended for use of collecting patient reported...
Ellodi eCOA App is intended for use of collecting patient reported outcomes...
Study diary is for participants to record side effects that occur after...
Roche eCOA App is intended for use to collect patient-reported outcomes relating...
Reata eCOA App is intended for use to collect patient reported outcomes...
Created with AppPage.net
Similar Apps - visible in preview.